Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma

Recently, combination regimens based on programmed cell death-1 (PD-1) blockade have become increasingly common in clinical practice for the treatment of cancer. Such combinations significantly improve efficacy, but treatment-related adverse events have also become more complex and severe. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yonghao, Li, Jun, Till, Brian G., Wang, Jun, Zhang, Bicheng, Wang, Hanping, Huang, Hao, Li, Tiepeng, Gao, Quanli, Li, Hongle, Wang, Zibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586206/
https://www.ncbi.nlm.nih.gov/pubmed/34778042
http://dx.doi.org/10.3389/fonc.2021.728253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586206/
https://www.ncbi.nlm.nih.gov/pubmed/34778042
http://dx.doi.org/10.3389/fonc.2021.728253

Ejemplares similares